Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing the previous v3.6.5, indicating a new site release. This update does not alter the study details or records on the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag on the Record History page updated from v3.6.4 to v3.6.5, indicating a new version of the site's software behind the history view. This change is an internal version bump rather than an update to study data or visible content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe study record history now shows a new revision tag v3.6.4, updating the page version from the previous v3.6.3. This reflects a minor metadata update to the page history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe history now shows an added revision entry v3.6.3 and a removed revision entry v3.6.0, updating the page's versioning log. This change updates the metadata shown in the history section without altering study content or functionality.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a note that recruitment is closed and updated the page revision to v3.6.0, replacing the previous v3.5.5 label.SummaryDifference0.2%

- Check88 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the history list, replacing the previous 'Revision: v3.5.4'. This represents a small site-build update reflected in the version history and does not change the underlying study records or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.